- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02474823
Neck Grasp as a Predictor of Sleep Apnea
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal is to evaluate the ESAP study (simple neck grasp) as a predictor of Obstructive Sleep Apnea (OSA) in combination with, and in comparison to; Home Sleep Test ( HST), Berlin Sleep Questionnaire and STOP-BANG questionnaire. All predictors are being evaluated against the gold standard test, the polysomnogram (PSG).
OSA is the common disorder affecting 3-7% of the adult population. It has many negative health consequences such as; cardiovascular disease, diabetes, motor vehicle accidents and depression. Data from both epidemiological and clinical studies suggest that OSA is also independently associated with alterations in glucose metabolism and places patients at an increased risk of the development of type 2 diabetes It is often missed in a busy practice. This simple diagnostic tool may help us in identifying the patient at an earlier stage, thus also helping to prevent further complications in diabetic patients.
Participants will undergo 3 study visits/procedures:
Visit 1: Participants will be consented for the study, undergo the ESAP test, complete the Berlin Sleep Questionnaire & STOP-BANG questionnaire, and provide medical history/demographic information.
Visit 2: Participants will undergo a PSG at the Bassett Sleep Lab.. Visit 3: The morning the PSG is completed, participants will be given the HST recorder and instructed in its use in order to complete the HST. Participants can then drop off the HST recorder at any Bassett Clinic and it will be returned to the Sleep Lab in Cooperstown.
The ESAP test, Berlin Sleep Questionnaire, and the STOP-BANG Questionnaire will be administered by a study coordinator, research nurse, and/or research assistant. The PSG and the HST will be read and evaluated by independent evaluators/physicians. These physicians will not have access to the ESAP or the questionnaire results prior to the evaluation of the PSG or HST.
If a participant has any test (except the ESAP test alone) that is indicative or suspicious for OSA, a study physician will review these results and advise them of any further follow up recommendations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Cooperstown, New York, United States, 13326
- Bassett Healthcare Network
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 - 70 years old regardless of gender
- Confirmed diagnosis of Type 2 diabetes
Exclusion Criteria:
- Unstable Heart failure
- COPD
- Neuromuscular disease
- Mental disorders which would interfere with following directions
- Persons who are already diagnosed with OSA or persons who have been using CPAP or BiPAP
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Sleep Apnea assessment
all participants are in the same arm & undergo the same assessments: PSG, HST, ESAP
|
all participants will undergo PSG for assessment of OSA
Other Names:
all participants will undergo HST for assessment of OSA
Other Names:
all participants will undergo ESAP for assessment of OSA
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Result of ESAP testing
Time Frame: 3 months
|
The ESAP measures a participant's ability to wrap their own hands around their neck, touching thumb to thumb, middle finger to middle finger.
A "positive" test (unable to reach around the neck with fingers) would be indicative of the presence of OSA.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
results of HST
Time Frame: 3 months
|
Positive HST would indicate presence of OSA
|
3 months
|
|
Result of PSG testing
Time Frame: 3 months
|
Positive PSG would indicate presence of OSA
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: lee edmonds, MD, Bassett Healthcare
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012 (ANMAR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Isabel Moreno HayAmerican Academy of Dental Sleep MedicineRecruitingObstructive Sleep Apnea (SAOS) | Obstructive Sleep Apnea (OSAS)United States
-
Mayo ClinicEnrolling by invitationObstructive Sleep Apnea | OSA | Obstructive Sleep Apnea (OSA)United States
-
Mardin Artuklu UniversityNot yet recruitingObstructive Sleep Apnea | Sleep ApneaTurkey (Türkiye)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); ResMed FoundationRecruitingObstructive Sleep Apnea | Sleep ApneaUnited States
-
Hospices Civils de LyonNot yet recruitingObstructive Sleep ApneaFrance
-
University Hospital, AntwerpNot yet recruiting
-
Nyxoah Inc.Not yet recruitingObstructive Sleep ApneaUnited States
-
Restera, Inc.RecruitingObstructive Sleep ApneaAustralia
Clinical Trials on polysomnogram
-
MetroHealth Medical CenterTeva Pharmaceuticals USACompletedObstructive Sleep ApneaUnited States
-
State University of New York at BuffaloVA Office of Research and DevelopmentWithdrawnSleep ApneaUnited States
-
Pontificia Universidad Catolica de ChileAgencia Nacional de Investigación y DesarrolloRecruitingApnea of Prematurity | Hypoxemia | PretermChile
-
University of FloridaWithdrawnHeart Failure | Obstructive Sleep Apnea | Sleep Apnea | Congestive Heart FailureUnited States
-
Albert Einstein Healthcare NetworkWithdrawnHypertension | Sleep ApneaUnited States
-
Fitbit IncActive, not recruitingSleep ApneaUnited States, Ireland
-
Douglas ScharreAvid Radiopharmaceuticals; Mangurian FoundationRecruitingParkinson's Disease | Alzheimer's Disease | Lewy Body DementiaUnited States
-
Woolcock Institute of Medical ResearchRecruitingOSA | COPD | Overlap SyndromeAustralia